Mounjaro — Nutrient Associations & Health Patterns
Also known as: Tirzepatide (Mounjaro, Zepbound)
Drug Class: GLP-1/GIP dual receptor agonist
Mounjaro is a GLP-1/GIP dual receptor agonist that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Mounjaro.
Reported Nutrient Associations for Mounjaro
Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.
- Vitamin B12
- Folic acid
- Vitamin D
- Zinc
- Iron
- Magnesium
Common Side Effects of Mounjaro
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Decreased appetite
- Abdominal pain
- Pancreatitis risk
- Thyroid tumor risk (in animal studies)
Key Drug Interactions — Mounjaro
Mounjaro has 6 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Insulin
- Sulfonylureas
- Other diabetes medications
- Oral contraceptives (reduced absorption — use backup method)
- Oral medications (delayed gastric emptying affects absorption)
- Warfarin
Frequently Asked Questions
What nutrient associations are reported for Mounjaro?
Mounjaro has reported nutrient associations involving Vitamin B12, Folic acid, Vitamin D, Zinc, Iron, Magnesium in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.
Which nutrient relationships are mapped for Mounjaro?
WePattern maps reported associations involving: Vitamin B12, Folic acid, Vitamin D, Zinc, Iron, Magnesium. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.
What are the side effects of Mounjaro?
Common side effects associated with Mounjaro include: Nausea; Vomiting; Diarrhea; Constipation; Decreased appetite.